Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice

Carcinogenesis

Volumn 20, Issue 8, 1999, Pages 1583-1590

  Christensen, James G ^a,b,d   Romach, Elizabeth H ^a,c   Healy, Laura N ^a   Gonzales, Andrea J ^a,d   Anderson, Steven P ^a   Malarkey, David E ^b   Corton, J Christopher ^a   Fox, Tony R ^a,c   Cattley, Russell C ^a   Goldsworthy, Thomas L ^a,e  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United States)

^d PFIZER INC   (United States)

^e INTEGRATED LABORATORY SYSTEMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENOBARBITAL; PIRINIXIC ACID; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CARCINOMA; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY;

ADENOMA; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CARCINOGENS; CARCINOMA; CARRIER PROTEINS; CHLORDAN; DNA-BINDING PROTEINS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; NEOPLASM PROTEINS; PHENOBARBITAL; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRIMIDINES; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION FACTORS;

EID: 0032818872     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.8.1583     Document Type: Article

References (61)

1. Chen, C. (1984) NTP Technical Report on the Toxicology and Characterization Studies of Dimethylmorpheno-phosphoramidate in F344/ n Rats and B6C3F1 Mice. Greene Publishing Associates and Wiley-Interscience, New York, NY.
2. Gold, L.S., Slone, T.H., Manley, N.B. and Bernstein, L. (1991) Target organs in chronic bioassays of 533 chemical carcinogens. Environ. Health Perspect., 93, 233-246.
3. Gold, L.S., Manley, N.B., Slone, T.H., Garfinkel, G.B., Rohrbach, L. and Ames, B.N. (1993) The fifth plot of the carcinogenic potency database: results of animal bioassay published in the general literature through 1989. Environ. Health Perspect., 100, 65-135.
4. Grasso, P. and Hardy, J. (1975) Strain differences in natural incidences and response to carcinogenesis. In Butler, W.H. and Newberne, P.M. (eds) Mouse Hepatic Neoplasia. Elsevier, New York, NY, p. 111.
5. Tennant, R. and Zeiger, E. (1993) Genetic toxicology: current status of methods of carcinogen identification. Environ. Health Perspect., 100, 307-315.
6. Tennant, R.W., Margolin, B.H., Shelby, M.D. et al. (1987) Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science, 236, 933-941.
7. Columbano, A., Ledda-Columbano, G.M., Rao, P.M., Rajalakshmit, S. and Sarma, D.S.R. (1984) Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells: a sequential study. Am. J. Pathol., 116, 441-446.
8. Schulte-Hermann, R., Grasl-Kraupp, B. and Bursch, W. (1995) Apoptosis and hepatocarcinogenesis. In Jirtle, R.J. (ed.) Liver Regeneration and Carcinogenesis. Academic Press, San Diego, CA, pp. 141-178.
9. Schulte-Hermann, R., Bursch, W. and Grasl-Kraupp, B. (1995) Active cell death (apoptosis) in liver biology and disease. In Boyer, J.L. and Ockner, R.K. (eds) Progress in Liver Disease. W.B. Saunders, Philadelphia, PA, Vol. XIII, pp. 1-35.
10. Bursch, W. and Lauer, B. (1983) Influence of liver tumor promoters on cell death by apoptosis in mouse liver. Arch. Pharmacol., 322 (suppl.), R119.
11. Bursch, W., Lauer, B., Timmerman-Trosiener, I., Barthel, G., Schuppler, J. and Schulte-Hermann, R. (1984) Controlled cell death (apoptosis) of normal and putative neoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis, 5, 53-58.
12. Schulte-Hermann, R., Timmerman-Trosiener, I. and Schuppler, J. (1982) Response of liver foci in rats to hepatic tumor promoters. Toxicol. Pathol., 10, 63-70.
13. Schulte-Hermann, R., Timmerman-Trosnier, I., Barthel, G. and Bursch, W. (1990) DNA synthesis, apoptosis and phenotypic expression as determinants of growth altered foci in rat liver during phenobarbital promotion. Cancer Res., 50, 5127-5135.
14. Malarkey, D., Devereaux, T., Dinse, G., Mann, P. and Maronpot, R. (1995) Hepatocarcinogenicity of chlordane in B6C3F1 and B6D2F1 male mice: evidence for regression in B6C3F1 mice independent of ras proto-oncogene activation. Carcinogenesis, 16, 2617-2625.
15. Grasl-Kraupp, B., Ruttkay-Nedecky, B., Mullauer, L., Taper, H., Huber, W., Bursch, W. and Schulte-Hermann, R. (1997) Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology, 25, 906-912.
16. Moolgavkar, S.H., Luebeck, E.G., Buchmann, A. and Bock, K.W. (1996) Quantitative analysis of enzyme altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol., 138, 31-42.
17. Stinchcombe, S., Buchmann, A., Bock, K.W. and Schwartz, M. (1995) 2,3,7,8-Tetrachlorodibebzo-p-dioxin mediated tumor promotion in the rat liver. Carcinogenesis, 16, 1271-1275.
18. Cleary, M.L. and Sklar, J. (1985) Nucleotide sequence of a t(14:18) chromosomal breakpoint in follicular lympoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl Acad. Sci. USA, 82, 7439-7443.
19. Tsujimoto, Y., Cossman, J., Jaffe, E. and Croce, C.M. (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science, 228, 1440-1443.
20. Bakhshi, A., Jensen, J.P., Goldman, P., Wright, J.J., McBride, O.W., Epstein, A.L. and Korsmeyer, S.J. (1985) Cloning the chromosomal breakpoint of t(14:18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on chromosome 18. Cell, 41, 899-906.
21. Reed, J.C. (1994) Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124, 1-6.
22. Hockenberry, D., Nunez, G., Milliman, C., Schreiber, R.D. and Korsmeyer, S.J. (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348, 334-336.
23. Vaux, D.L., Cory, S. and Adams, J.M. (1988) Bcl-2 gene promotes haemotopoetic cell survival and cooperates with c-myc to immortalize pre-B cells, Nature, 335, 440-442.
24. Yin, X.-M., Oltvai, Z.N. and Korsmeyer, S.J. (1994) BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature, 369, 321-323.
25. Williams, G.T. and Smith, C.A. (1993) Molecular regulation of apoptosis: genetic controls on cell death. Cell, 74, 777-779.
26. Oltvai, Z.N., Milliman, C.L. and Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates cell death. Cell, 74, 609-619.
27. Boise, L.H., Gonzalez-Garcia, M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nunez, G. and Thompson, C.B. (1993) Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptosis. Cell, 74, 597-608.
28. Takayama, S., Sato, T., Krajewski, S., Kochel, K., Irie, S., Millan, J.A. and Reed, J.C. (1995) Cloning and functional analysis of BAG-1: a novel bcl-2 binding protein with anti-cell death activity. Cell, 80, 279-284.
29. Sato, T., Hanada, M., Bodrug, S. et al. (1994) Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl Acad. Sci. USA, 91, 9238-9242.
30. Reed, J.C. (1998) Dysregulation of apoptosis in cancer. Cancer J. Sci. Am., 1, S8-14.
31. Christensen, J.G., Gonzales, A.J., Cattley, R.C. and Goldsworthy, T.L. (1998) Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens. Cell Growth Differ., 9, 815-825.
32. Lee, G.-H., Ooasa, T.O. and Osanai, M. (1998) Mechanism of the paradoxical, inhibitory effect of phenobarbital on hepatocarcinogenesis in infant B6C3F1 mice with diethylnitrosamine. Cancer Res., 58, 1665-1669.
33. Lee, G.-H. (1997) Correlation between bcl-2 expression and histopathology in diethylnitrosamine-induced mouse hepatocellular tumors. Am. J. Pathol., 151, 957-961.
34. Peters, J.M., Cattley, R.C. and Gonzalez, F.J. (1997) Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator WY-14,643. Carcinogenesis, 18, 2029-2033.
35. Romach, E.H., Goldsworthy, T.L., Maronpot, R.R. and Fox, T.R. (1997) Altered gene expression in spontaneous hepatocellular carcinomas from male B6C3F1 mice. Mol. Carcinog., 19, 31-38.
36. Frith, C.H. and Ward, J.M. (1980) A morphologic classification of proliferative and neoplastic hepatic lesions in mice. J. Environ. Pathol. Toxicol., 3, 329-351.
37. Maronpot, R.R., Haseman, J.K., Boorman, G.A., Eustis, S.E., Rao, G.N. and Huff, J.E. (1987) Liver lesions in B6C3F1 mice: the National Toxicology Program, experience and position. Arch. Toxicol., 10 (suppl.), 10-26.
38. Ward, J.M. (1980) Morphology of hepatocellular neoplasms in B6C3F1 mice. Cancer Lett., 9, 319-325.
39. Takayama, S., Krajewski, S., Krajewska, M. et al. (1998) Expression and localization of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res., 58, 3116-3131.
40. Sanders, S. and Thorgeirsson, S.S. (1999) Phenobarbital promotes growth in c-myc/TGF-α mice by hypertrophy and inhibiting apoptosis. Carcinogenesis, 20, 41-49.
41. Butler, W.H. (1979) Pesticide related lesions in the liver and their interpretation. In Emmelot, P. and Kriek, E. (eds) Environmental Carcinogenesis. Elsevier, Amsterdam, The Netherlands, pp. 193-201.
42. Kolaja, K.L., Stevenson, D.E., Johnson, J.T., Walborg, E.F. Jr, and Klaunig, J.E. (1996) Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. Fundam. Appl. Toxicol., 29, 219-228.
43. Orton, T.C., Doughty, S.E., Kalinowski, A.E., Lord, P.G. and Wadsworth, P.F. (1996) Expression of growth factors and growth factor receptors in the liver of C57BL/10J mice following administration of phenobarbitone. Carcinogenesis, 17, 973-981.
44. Webber, E.M., Wu, J.C., Wang, L., Merlino, G. and Fausto, N. (1994) Overexpression of transforming growth factor alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am. J. Pathol., 145, 398-408.
45. Oberhammer, F.A., Fritsch, G., Pavelka, M., Froschl, G., Tiefenbacher, R., Purchio, T. and Schulte-Hermann, R. (1992) Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc. Natl Acad. Sci. USA, 89, 5408-5412.
46. Nakamura, T., Tomita, Y., Hirai, R., Yamacoca, K., Kaji, K. and Ichihara, A. (1985) Inhibitory effect of transforming growth factor-beta on DNA synthesis of adult rat hepatocytes in primary culture. Biochem. Biophys. Res. Commun., 133, 1042-1050.
47. Christensen, J.G., Goldsworthy, T.L. and Cattley, R.C. (1999) Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens. Mol. Carcinog., in press.
48. Wastl, U.M., Rossmanith, W., Lang, M.A., Camus-Randon, A.M., Grasl-Kraupp, B., Bursch, W. and Schulte-Hermann, R. (1998) Expression of cytochrome P450 2A5 in preneoplastic and neoplastic mouse liver lesions. Mol. Carcinog., 22, 229-234.
49. Metzger, C., Mayer, D., Hoffmann, H., Bocker, T., Hobe, G., Benner, A. and Bannasch, P. (1995) Sequential appearance and ultrastructure of amphophilic cell foci, adenomas and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone. Toxicol. Pathol., 23, 591-605.
50. Beier, K., Volkl, A., Metzger, C., Mayer, D., Bannasch, P. and Fahimi, H.D. (1997) Hepatic zonation of the induction of cytochrome P450 IVA, peroxisomal lipid beta-oxidation enzymes and peroxisome proliferation in rats treated with dehydroepiandrosterone (DHEA). Evidence of distinct zonal and sex-specific differences. Carcinogenesis, 18, 1491-1498.
51. Ward, J.M., Rice, J.M., Creasia, D., Lynch, P. and Riggs, C. (1983) Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice. Carcinogenesis, 4, 1021-1029.
52. Ward, J.M., Ohshima, M., Lynch, P. and Riggs, C. (1984) Di(2-ethylhexyl)phthalate but not phenobarbital promotes N-nitrosodiethyl amine initiated hepatocellular proliferative lesions after short term exposure in male B6C3F1 mice. Cancer Lett., 24, 49-55.
53. Moser, G.J., Wolf, D.C. and Goldsworthy, J.L. (1997) Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver. Toxicol. Pathol., 25, 275-283.
54. Moser, G. and Goldsworthy, T.L. (1996) Growth factor regulation in mouse liver Carcinogenesis. CIIT Activities, 16, 1-8.
55. Pitot, H.C. (1990) Protooncogene activation in multistage murine hepatocarcinogenesis. In Stevenson, D.E., McClain, R.M., Popp, J.A., Ward, J.M., Slaga, T.J. and Pitot, H.C. (eds) Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons. Wiley-Liss, New York, NY, Vol. 331, pp. 311-324.
56. Ward, J.M., Diwan, B.A., Lubet, R.A., Henneman, J.R. and Devor, D.E. (1990) Liver tumor promoters and other mouse carcinogens. In Stevenson, D.E., McClain, R.M., Popp, J.A., Ward, J.M., Slaga, T.J. and Pitot, H.C. (eds) Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons. Wiley-Liss, New York, NY, Vol. 331, pp. 85-108.
57. Maronpot, R.R., Fox, T., Malarkey, D.E. and Goldsworthy, T.L. (1995) Mutations in the ras protooncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology, 101, 125-156.
58. Nass, S.J., Li, M., Amundadottir, L.T., Furth, P.A. and Dickson, R.B. (1996) Role for bcl-xL in the regulation of apoptosis by EGF and TGF-betal in c-myc overexpression mammary epithelial cells. Biochem. Biophys. Res. Commun., 227, 248-256.
59. Kinoshita, T., Yokota, T., Arai, K. and Miyajima, A., (1995) Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoetic cells. Oncogene, 10, 2207-2212.
60. Tsuda, H., Hirohashi, S., Shimosato, Y., Ino, Y., Yoshida, T. and Terada, M. (1989) Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma. Jpn J. Cancer Res., 80, 196-199.
61. Charlotte, F., I'Hermine, A., Martin, N., Geleyn, Y., Nollet, M., Gaulard, P. and Zafrani, E.S. (1994) Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am. J. Pathol., 144, 441-446.